InfectionNovel antifungal compounds are more potent and less toxic – and will be lower costScientists in the U.K. have used genome mining to identify bacterial species capable of producing novel polyene antifungal compounds that are both more effective and have a more benign side effect profile than approved polyenes such as amphotericin and nystatin.